A detailed history of Aull & Monroe Investment Management Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, Aull & Monroe Investment Management Corp holds 19,620 shares of ABBV stock, worth $3.24 Million. This represents 1.82% of its overall portfolio holdings.

Number of Shares
19,620
Previous 19,653 0.17%
Holding current value
$3.24 Million
Previous $3.37 Million 14.96%
% of portfolio
1.82%
Previous 1.67%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$163.84 - $199.33 $5,406 - $6,577
-33 Reduced 0.17%
19,620 $3.87 Million
Q2 2024

Jul 19, 2024

SELL
$154.79 - $180.76 $353,230 - $412,494
-2,282 Reduced 10.4%
19,653 $3.37 Million
Q1 2024

May 06, 2024

SELL
$159.82 - $182.1 $69,521 - $79,213
-435 Reduced 1.94%
21,935 $3.99 Million
Q4 2023

Jan 25, 2024

SELL
$137.6 - $154.97 $50,912 - $57,338
-370 Reduced 1.63%
22,370 $3.47 Million
Q3 2023

Nov 13, 2023

SELL
$133.59 - $154.65 $26,718 - $30,930
-200 Reduced 0.87%
22,740 $3.39 Million
Q1 2023

May 12, 2023

BUY
$144.61 - $166.54 $12,147 - $13,989
84 Added 0.37%
22,940 $3.66 Million
Q4 2022

Feb 07, 2023

SELL
$138.31 - $165.87 $84,922 - $101,844
-614 Reduced 2.62%
22,856 $3.7 Million
Q1 2022

May 02, 2022

SELL
$131.98 - $163.75 $3,299 - $4,093
-25 Reduced 0.11%
23,470 $3.81 Million
Q4 2021

Feb 02, 2022

SELL
$107.43 - $135.93 $22,990 - $29,089
-214 Reduced 0.9%
23,495 $3.18 Million
Q3 2021

Oct 26, 2021

BUY
$106.4 - $120.78 $5,320 - $6,039
50 Added 0.21%
23,709 $2.56 Million
Q1 2021

Apr 19, 2021

BUY
$102.3 - $112.62 $50,740 - $55,859
496 Added 2.14%
23,659 $2.56 Million
Q4 2020

Feb 02, 2021

SELL
$80.49 - $108.67 $9,739 - $13,149
-121 Reduced 0.52%
23,163 $2.48 Million
Q3 2020

Nov 02, 2020

BUY
$85.91 - $100.83 $120,274 - $141,162
1,400 Added 6.4%
23,284 $2.04 Million
Q2 2020

Jul 28, 2020

SELL
$73.37 - $98.18 $141,237 - $188,996
-1,925 Reduced 8.09%
21,884 $2.15 Million
Q1 2020

Apr 22, 2020

SELL
$64.5 - $97.79 $4,837 - $7,334
-75 Reduced 0.31%
23,809 $1.81 Million
Q4 2019

Feb 04, 2020

SELL
$72.13 - $90.25 $39,671 - $49,637
-550 Reduced 2.25%
23,884 $2.12 Million
Q3 2019

Oct 30, 2019

SELL
$62.98 - $75.72 $74,946 - $90,106
-1,190 Reduced 4.64%
24,434 $1.85 Million
Q2 2019

Jul 29, 2019

SELL
$65.7 - $83.98 $19,710 - $25,194
-300 Reduced 1.16%
25,624 $1.86 Million
Q1 2019

Apr 18, 2019

SELL
$77.14 - $90.79 $80,997 - $95,329
-1,050 Reduced 3.89%
25,924 $2.09 Million
Q4 2018

Feb 13, 2019

SELL
$77.85 - $96.01 $105,097 - $129,613
-1,350 Reduced 4.77%
26,974 $2.49 Million
Q3 2018

Oct 31, 2018

SELL
$88.91 - $98.84 $35,564 - $39,536
-400 Reduced 1.39%
28,324 $2.68 Million
Q2 2018

Jul 24, 2018

SELL
$89.78 - $106.23 $26,934 - $31,869
-300 Reduced 1.03%
28,724 $2.66 Million
Q1 2018

May 10, 2018

SELL
$92.01 - $123.21 $9,201 - $12,321
-100 Reduced 0.34%
29,024 $2.75 Million
Q4 2017

Jan 29, 2018

SELL
$89.56 - $98.21 $60,900 - $66,782
-680 Reduced 2.28%
29,124 $2.82 Million
Q2 2017

Aug 14, 2017

BUY
N/A
29,804
29,804 $2.16 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $292B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Aull & Monroe Investment Management Corp Portfolio

Follow Aull & Monroe Investment Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aull & Monroe Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Aull & Monroe Investment Management Corp with notifications on news.